The present study showed that when carefully applied and monitored, the application of 35 1-hour daily sessions of EECP over approximately 7 weeks was safe and well-tolerated in patients with ...
During the past decade, there have been an increasing number of patients with anginal symptoms who are not suitable candidates for revascularization procedures. It is this group of patients who appear ...
In a small study of long COVID-19 patients, those with and without coronary artery disease demonstrated improvement of a variety of symptoms, including fatigue, breathing difficulties and chest ...
In a small study of long COVID-19 patients, those with and without coronary artery disease demonstrated improvement of a variety of symptoms, including fatigue, breathing difficulties and chest ...
Westbury, NY (Vocus) October 21, 2010-- Vasomedical, Inc. (“ Vasomedical”) (OTC: VASO.OB), a world leader in the noninvasive treatment of cardiovascular diseases, today announced the online ...
PITTSBURGH, Feb. 27 – Patients with angina (chest pain) and left ventricular dysfunction respond very well to treatment using enhanced external counterpulsation (EECP), with little or no future heart ...
PANAMA CITY, Fla. (WJHG/WECP) - It’s a therapy aimed at relieving chest pain. Dr. Amir R. Haghighat with the Cardiovascular Institute of Northwest Florida explains that while Enhanced External ...
Enhanced External Counterpulsation Therapy (EECP) is a unique, non-invasive or alternative therapy for people that continue to have chest pain or pressure that are unable to have standard treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback